IL195867A0 - Use of adenosine a1 antagonist in radiocontrast media induced nephropathy - Google Patents

Use of adenosine a1 antagonist in radiocontrast media induced nephropathy

Info

Publication number
IL195867A0
IL195867A0 IL195867A IL19586708A IL195867A0 IL 195867 A0 IL195867 A0 IL 195867A0 IL 195867 A IL195867 A IL 195867A IL 19586708 A IL19586708 A IL 19586708A IL 195867 A0 IL195867 A0 IL 195867A0
Authority
IL
Israel
Prior art keywords
adenosine
antagonist
induced nephropathy
radiocontrast media
media induced
Prior art date
Application number
IL195867A
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of IL195867A0 publication Critical patent/IL195867A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL195867A 2006-06-19 2008-12-11 Use of adenosine a1 antagonist in radiocontrast media induced nephropathy IL195867A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06115673 2006-06-19
EP06126589 2006-12-20
PCT/EP2007/056034 WO2007147809A1 (en) 2006-06-19 2007-06-18 Use of adenosine a1 antagonist in radiocontrast media induced nephropathy

Publications (1)

Publication Number Publication Date
IL195867A0 true IL195867A0 (en) 2009-09-01

Family

ID=38521148

Family Applications (1)

Application Number Title Priority Date Filing Date
IL195867A IL195867A0 (en) 2006-06-19 2008-12-11 Use of adenosine a1 antagonist in radiocontrast media induced nephropathy

Country Status (11)

Country Link
EP (1) EP2035007A1 (en)
JP (1) JP2009541256A (en)
KR (1) KR20090029727A (en)
AU (1) AU2007263036A1 (en)
BR (1) BRPI0713126A2 (en)
CA (1) CA2655016A1 (en)
EA (1) EA200802402A1 (en)
IL (1) IL195867A0 (en)
MX (1) MX2008016255A (en)
TW (1) TW200808819A (en)
WO (1) WO2007147809A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ302486B6 (en) * 1998-06-02 2011-06-15 Osi Pharmaceuticals, Inc. N-6-Substituted-7-deazapurine, process for its preparation and pharmaceutical composition containing thereof
KR100840727B1 (en) * 1999-12-02 2008-06-23 오에스아이 파마슈티컬스, 인코포레이티드 Compounds specific to adenosine £á1, £á2£á and £á3 receptor and uses thereof
BR0115847A (en) * 2000-12-01 2004-02-25 Osi Pharm Inc Adenosine Receptor Specific Compounds a1, a2a, and a3 and Uses
US20040229901A1 (en) * 2003-02-24 2004-11-18 Lauren Otsuki Method of treatment of disease using an adenosine A1 receptor antagonist
AR043880A1 (en) * 2003-04-22 2005-08-17 Solvay Pharm Gmbh ACID MESILATE 4- (4.TRANS-HYDROXICICLOHEXIL) AMINO-2-PHENYL-7H-PIRROLO (2,3-D) PYRIMIDINE AND ITS POLYMORPHAS FORMS

Also Published As

Publication number Publication date
JP2009541256A (en) 2009-11-26
KR20090029727A (en) 2009-03-23
EP2035007A1 (en) 2009-03-18
AU2007263036A1 (en) 2007-12-27
BRPI0713126A2 (en) 2012-04-10
CA2655016A1 (en) 2007-12-27
MX2008016255A (en) 2009-01-15
EA200802402A1 (en) 2009-06-30
TW200808819A (en) 2008-02-16
WO2007147809A1 (en) 2007-12-27

Similar Documents

Publication Publication Date Title
HUS2200052I1 (en) Imidazotriazines and imidazopyrimidines as kinase inhibitors
HK1144306A1 (en) Kinase inhibitors and uses thereof
IL193496A (en) Indicating agents for use in evaluating mental conditions
IL211549A0 (en) Aminotriazolopyridines and their use as kinase inhibitors
EP1991366A4 (en) Water-based faux finish and methods
EP2109814A4 (en) Hybrid evaluation of expressions in dbms
GB201000648D0 (en) Phosphodiesterase 10 inhibitors
EP2024192A4 (en) Multicolor writing tools and methods
EP2379076A4 (en) Phosphodiesterase inhibitors and uses thereof
IL195817A0 (en) Use of 2-benzoyl-imidazopyridines in therapeutics
EP2415870A4 (en) Rnai molecule for thymidylate synthase and use thereof
EP2357229A4 (en) Hydroxylase gene and use thereof
IL195867A0 (en) Use of adenosine a1 antagonist in radiocontrast media induced nephropathy
GB0708411D0 (en) Lanthanide probes
GB0703514D0 (en) Use of riboflavin
GB0614982D0 (en) Improvements in craft kits
EP2033402A4 (en) Improved use of parallel media flows
EP1986821A4 (en) Sleeve for use in making abrasive articles
EP2155209A4 (en) Dna polymerase inhibitors composition and methods
GB0622367D0 (en) Phosphodiesterase inhibitors
GB2443106B (en) Improvements in craft kits
GB0621149D0 (en) Float for use in angling
GB0617609D0 (en) Stowable bridge
AP2009004815A0 (en) Inhibitors of phosphodiesterase type-IV
GB0622545D0 (en) In-car co2 meter